Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Vaccines |
Free Subscription
2 AIDS |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Vaccines is free of charge.
Adverse drug reaction profile of third-generation smallpox vaccines used in
France during the 2022 monkeypox epidemic.
AIDS. 2024;38:768-771.
PubMed
Abstract available
PrEP Availability Among Health Facilities Participating in the Global IeDEA
Consortium.
AIDS. 2023 Dec 22. doi: 10.1097/QAD.0000000000003824.
PubMed
Abstract available
Correlates of immune protection against human rotaviruses: natural infection and
vaccination.
Arch Virol. 2024;169:72.
PubMed
Abstract available
Population-based cross-sectional study of factors influencing full vaccination
status of children aged 12- 23 months in a rural district of the Upper East
Region, Ghana.
BMC Pediatr. 2024;24:168.
PubMed
Abstract available
Immunogenicity and Safety of a Purified Vero Rabies Vaccine - Serum Free,
Compared With Two Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen
in Healthy Adults in France: A Randomized Controlled Phase III Trial.
Clin Infect Dis. 2024 Mar 13:ciae137. doi: 10.1093.
PubMed
Abstract available
Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA
Vaccine.
Clin Infect Dis. 2024 Mar 11:ciae132. doi: 10.1093.
PubMed
Abstract available
Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease
vaccine antigen, outer surface protein A (OspA).
Infect Immun. 2024 Mar 12:e0008424. doi: 10.1128/iai.00084.
PubMed
Abstract available
Licorice extract inhibits porcine epidemic diarrhea virus in vitro and in vivo.
J Gen Virol. 2024;105.
PubMed
Abstract available
High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men.
J Infect Dis. 2023 Nov 28:jiad485. doi: 10.1093.
PubMed
Abstract available
Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus
Disease 2019 Vaccine Booster.
J Infect Dis. 2024;229:644-647.
PubMed
Abstract available
Effect of pneumococcal conjugate vaccines on viral respiratory infections: a
systematic literature review.
J Infect Dis. 2024 Mar 11:jiae125. doi: 10.1093.
PubMed
Abstract available
Prevalence of Human Papillomavirus (HPV) and HPV Type Distribution in Penile
Samples in Young Men in Denmark: Results 10 Years After Implementation of a
Girls-Only HPV Vaccination Program.
J Infect Dis. 2024 Mar 12:jiae068. doi: 10.1093.
PubMed
Abstract available
Safety and Immunogenicity of a Messenger RNA-Based Cytomegalovirus Vaccine in
Healthy Adults: Results From a Phase 1, Randomized, Clinical Trial.
J Infect Dis. 2024 Mar 13:jiae114. doi: 10.1093.
PubMed
Abstract available
Mpox-specific immune responses elicited by vaccination or infection in people
living with HIV.
J Infect Dis. 2024 Mar 13:jiae138. doi: 10.1093.
PubMed
Abstract available
A bivalent Adenovirus-Vectored Vaccine induces a robust humoral response, but
does not protect cynomolgus macaques against a lethal challenge with Sudan virus.
J Infect Dis. 2024 Mar 15:jiae056. doi: 10.1093.
PubMed
Abstract available
A glass-half-full perspective on negative data in Ebolavirus vaccine studies.
J Infect Dis. 2024 Mar 15:jiae109. doi: 10.1093.
PubMed
New Prevention Guidance for Antibiotic-Resistant Meningococcal Cases.
JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0731.
PubMed
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster
campaign.
Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
PubMed
The great cholera vaccine shortage.
Lancet. 2024;403:891-892.
PubMed
mRNA-based therapeutics: looking beyond COVID-19 vaccines.
Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
PubMed
Abstract available
Maternal RSV Vaccine - Weighing Benefits and Risks.
N Engl J Med. 2024;390:1050-1051.
PubMed
RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other
Outcomes.
N Engl J Med. 2024;390:1009-1021.
PubMed
Abstract available
Antibody-independent protection against heterologous SARS-CoV-2 challenge
conferred by prior infection or vaccination.
Nat Immunol. 2024 Mar 14. doi: 10.1038/s41590-024-01787.
PubMed
Abstract available
A longitudinal study of the COVID-19 pandemic impact on mental health in
ophthalmic personnel and students.
PLoS One. 2024;19:e0300144.
PubMed
Abstract available
Uptake of COVID-19 vaccine among high-risk urban populations in Southern Thailand
using the COM-B model.
PLoS One. 2024;19:e0300509.
PubMed
Abstract available
Self- and informant-reported personality traits and vaccination against COVID-19.
PLoS One. 2024;19:e0287413.
PubMed
Abstract available
Predicting intention to vaccinate against COVID-19 in older Syrian refugees in
Lebanon: Findings from a multi-wave study.
Vaccine. 2024 Mar 13:S0264-410X(24)00213-5. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
The effect of a financial incentive on COVID-19 vaccination uptake, and
predictors of uptake, in people experiencing homelessness: A randomized
controlled trial.
Vaccine. 2024 Mar 13:S0264-410X(24)00307-4. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Expression of Concern: "Cross-protection against H7N9 influenza strains using a
live-attenuated H7N3 virus vaccine" [Vaccine [33/1], 1 January 2015, Pages
108-116].
Vaccine. 2024;42:1851.
PubMed
Expression of Concern: "Human COBRA 2 vaccine contains two major epitopes that
are responsible for eliciting neutralizing antibody responses against
heterologous clades of viruses" [Vaccine Volume 38, Issue 4, 22 January 2020,
Pages 830-839].
Vaccine. 2024;42:1850.
PubMed
Evaluation of the safety profile of the quadrivalent vaccine against human
papillomavirus in the risk of developing autoimmune, neurological, and
hematological diseases in adolescent women in Colombia.
Vaccine. 2024 Mar 7:S0264-410X(24)00263-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Four statistical frameworks for assessing an immune correlate of protection
(surrogate endpoint) from a randomized, controlled, vaccine efficacy trial.
Vaccine. 2024 Mar 7:S0264-410X(24)00247-0. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
A community-engaged approach to translate a Vaccine Hesitancy Scale into Haitian
Creole.
Vaccine. 2024 Mar 7:S0264-410X(24)00257-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
The Vaccine Training Barometer: Assessing healthcare providers' confidence to
answer vaccine-related questions and their training needs.
Vaccine. 2024 Mar 7:S0264-410X(24)00254-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Vaccination during pregnancy and modulation of IgG response to pertussis vaccines
in infants: The impact of different vaccine formulations.
Vaccine. 2024 Mar 8:S0264-410X(24)00300-1. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Pandemic antecedents - Exploring predictivity and relationships between COVID-19
vaccine uptake and influenza, shingles, and HPV vaccination.
Vaccine. 2024 Mar 8:S0264-410X(24)00275-5. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Safety and immunogenicity of heterologous boosting with a bivalent SARS-CoV-2
mRNA vaccine (XBB.1.5/BQ.1) in Chinese participants aged 18 years or more: A
randomised, double-blinded, active-controlled phase 1 trial.
Vaccine. 2024 Mar 8:S0264-410X(24)00277-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Current vaccine strategies and novel approaches to combatting Francisella
infection.
Vaccine. 2024 Mar 8:S0264-410X(24)00264-0. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the
vaccine adverse event reporting System - United States, September 1, 2022 - March
31, 2023.
Vaccine. 2024 Mar 9:S0264-410X(24)00262-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
An inactivated whole-virion vaccine for Enterovirus D68 adjuvanted with CpG ODN
or AddaVax elicits potent protective immunity in mice.
Vaccine. 2024 Mar 11:S0264-410X(24)00303-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Partisan divide and Racial/Ethnic disparities in COVID-19 vaccine hesitancy among
Parents/Guardians and vaccine uptake among children in the U.S.
Vaccine. 2024 Mar 11:S0264-410X(24)00309-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Effectiveness of one and two doses of acellular pertussis vaccines against
laboratory-confirmed pertussis requiring hospitalisation in infants: Results of
the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015
- December 201
Vaccine. 2024 Mar 11:S0264-410X(24)00272-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Sociodemographic and Occupational Characteristics Associated with Early and
Continued COVID-19 Vaccine Uptake Among Healthcare Personnel: Monroe County, NY.
Vaccine. 2024 Mar 12:S0264-410X(24)00306-2. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
UK healthcare professionals' attitudes towards the introduction of varicella
vaccine into the routine childhood vaccination schedule and their preferences for
administration.
Vaccine. 2024 Mar 12:S0264-410X(24)00274-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Influences of mpox disease perceptions, sources and contents of information
exposure on mpox vaccine uptake among gay, bisexual, and other men who have sex
with men in Hong Kong, China.
Vaccine. 2024 Mar 12:S0264-410X(24)00259-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Varicella outbreak at nursery school under routine immunization in Japan in 2017
and 2018 and vaccine effectiveness.
Vaccine. 2024 Mar 12:S0264-410X(24)00250-0. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron
vaccine through enhanced humoral and cellular immunity.
Virology. 2024;594:110050.
PubMed
Abstract available
Thank you for your interest in scientific medicine.